1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. 2006; ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans-Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 113:e463–654. DOI:
10.1161/CIRCULATIONAHA.106.173994.
2. Valentine RJ, Jackson MR, Modrall JG, McIntyre KE, Clagett GP. 1999; The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service. J Vasc Surg. 30:436–44. DOI:
10.1016/S0741-5214(99)70070-4. PMID:
10477636.
Article
3. Barretto S, Ballman KV, Rooke TW, Kullo IJ. 2003; Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location. Vasc Med. 8:95–100. DOI:
10.1191/1358863x03vm475oa. PMID:
14518611.
Article
4. Norgren L, Hiatt WR, Dormandy JA, et al. 2007; Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 45 Suppl S:S5–67. DOI:
10.1016/j.jvs.2006.12.037. PMID:
17223489.
Article
5. Mehta A, Dhindsa DS, Hooda A, et al. 2021; Premature atherosclerotic peripheral artery disease: an underrecognized and undertreated disorder with a rising global prevalence. Trends Cardiovasc Med. 31:351–8. DOI:
10.1016/j.tcm.2020.06.005. PMID:
32565142.
Article
6. Ridker PM, Stampfer MJ, Rifai N. 2001; Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 285:2481–5. DOI:
10.1001/jama.285.19.2481. PMID:
11368701.
7. Conte MS, Pomposelli FB, et al. Society for Vascular Surgery Lower Extremity Guidelines Writing Group. 2015; Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 61(3 Suppl):2S–41S. DOI:
10.1016/j.jvs.2014.12.009. PMID:
25638515.
Article
8. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2017; 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 69:1465–508. DOI:
10.1016/j.jacc.2016.11.008. PMID:
27851991.
9. Cho S, Lee SH, Joh JH. 2019; Risk factors for asymptomatic peripheral arterial disease in Korean population: lessons from a community-based screening. Ann Surg Treat Res. 97:210–6. DOI:
10.4174/astr.2019.97.4.210. PMID:
31620395. PMCID:
PMC6779951.
Article